Anders Pedersen
Chairman bij AELIS FARMA
Vermogen: 3 M $ op 31-03-2024
Profiel
Anders Gersel Pedersen is currently the Chief Executive Officer at Gerselconsult ApS.
He is also the Deputy Chairman at Bavarian Nordic A and Bavarian Nordic GmbH.
Additionally, he serves as the Chairman of Fonden Lundbeck International Neuroscience Foundation and Aelis Farma SA. Dr. Pedersen is a Non-Independent Director at Genmab A and an Independent Director at Hansa Biopharma AB.
He is also a Director at Lundbeck Cognitive Therapeutics A, Bond 2 Development 2 Gp Ltd., and Bond Avillion 2 Development LP.
Furthermore, he is a Member of the American Society of Clinical Oncology, Inc., the European Society for Medical Oncology, the International Association for the Study of Lung Cancer, the Danish Society of Medical Oncology, and the Danish Society of Internal Medicine.
Dr. Pedersen joined Avillion LLP in 2019 as a Member-Supervisory Board.
Dr. Pedersen previously worked as an Executive Director at Eli Lilly & Co. He was also a Director at Topotarget A and Chr.
Hansen A.
Additionally, he served as a Director at TopoTarget UK Ltd.
Dr. Pedersen worked at H.
Lundbeck A from 2000 to 2018, where he held the position of Executive Vice President-Research & Development.
He was an Independent Director at ALK-Abello A from 2005 to 2018.
Dr. Pedersen completed his undergraduate studies at Copenhagen Business School and obtained a doctorate degree from the University of Copenhagen.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
GENMAB A/S
0.01% | 14-02-2024 | 9 292 ( 0.01% ) | 3 M $ | 31-03-2024 |
BAVARIAN NORDIC A/S
0.02% | 31-12-2022 | 16 959 ( 0.02% ) | 380 482 $ | 31-03-2024 |
HANSA BIOPHARMA AB
0.00% | 31-12-2022 | 2 500 ( 0.00% ) | 6 804 $ | 31-03-2024 |
Actieve functies van Anders Pedersen
Bedrijven | Functie | Begin |
---|---|---|
BAVARIAN NORDIC A/S | Director/Board Member | 27-04-2010 |
GENMAB A/S | Director/Board Member | 01-11-2003 |
HANSA BIOPHARMA AB | Director/Board Member | 29-05-2018 |
AELIS FARMA | Chairman | - |
Bond Avillion 2 Development LP | Director/Board Member | - |
Bond 2 Development 2 Gp Ltd. | Director/Board Member | - |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Director/Board Member | 05-09-2019 |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Director/Board Member | 01-01-2014 |
Lundbeck Cognitive Therapeutics A/S | Director/Board Member | - |
░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░ | - |
Eerdere bekende functies van Anders Pedersen
Bedrijven | Functie | Einde |
---|---|---|
░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░ ░░░░░ ░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Opleiding van Anders Pedersen
Copenhagen Business School | Undergraduate Degree |
University of Copenhagen | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 7 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
H. LUNDBECK A/S | Health Technology |
GENMAB A/S | Health Technology |
BAVARIAN NORDIC A/S | Health Technology |
ALK-ABELLÓ A/S | Health Technology |
HANSA BIOPHARMA AB | Health Technology |
AELIS FARMA | Health Technology |
Bedrijven in privébezit | 15 |
---|---|
Topotarget A/S
Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Chr. Hansen A/S
Chr. Hansen A/S Pharmaceuticals: OtherHealth Technology Chr. Hansen A/S engages in bioscience research that develops natural solutions for the food, nutritional, pharmaceutical and agricultural industries. It also develops and produces cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed. The company was founded by Christian D. A Hansen in 1874 and is headquartered in Horsholm, Denmark. | Health Technology |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade TopoTarget UK Ltd. engages in the discovery and development of drugs and therapies to treat cancer. It develops anti-cancer drugs for molecular mechanisms associated with the cell cycle, chromatin control and DNA damage. The company was founded in 2002 and is headquartered in Oxford, the United Kingdom. | Retail Trade |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services The European Society for Medical Oncology (ESMO) is a leading medical oncology society that provides a professional network for its members and works with national societies across Europe. The non-profit company is based in Lugano, Switzerland. ESMO's position on a wide range of legislative and non-legislative policy files on both EU and levels is available to learn about. Raffaella Casolino is the third ESMO young medical oncologist serving as a cancer expert on the WHO Cancer Control team. ESMO's Young Oncologists Corner is dedicated to providing educational and networking opportunities for medical oncologists under 40. | Health Services |
International Association for the Study of Lung Cancer | |
Danish Society of Medical Oncology | |
Danish Society of Internal Medicine | |
Fonden Lundbeck International Neuroscience Foundation | Miscellaneous |
Avillion LLP
Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Health Technology |
Bond 2 Development 2 Gp Ltd. | |
Bond Avillion 2 Development LP | |
Gerselconsult ApS | |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Health Technology |
Lundbeck Cognitive Therapeutics A/S |